| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/05/1997 | CN1141773A Preparation of medicine containing 6-oxo-azitropilidene indole |
| 02/05/1997 | CN1033976C Preparation of polypeptides used as blockers of calcium channels |
| 02/04/1997 | US5599991 Esylate and sulfate salts of R(+)-N-propargyl-1-aminoindan |
| 02/04/1997 | US5599972 Aminobenzoic acid derivatives |
| 02/04/1997 | US5599966 Substituted ethanolamine esters |
| 02/04/1997 | US5599941 Treatment of intestinal motility disorders |
| 02/04/1997 | US5599938 Process for preparing a piperidine derivative |
| 02/04/1997 | US5599937 Heteroaromatic quinuclidinenes, their use and preparation |
| 02/04/1997 | US5599936 Isoindolinone derivative, preparation thereof and pharmaceutical compositions containing same |
| 02/04/1997 | US5599821 4-heteroaryl-1-piperidinealkylamines and derivatives thereof and their therapeutic utility |
| 02/04/1997 | US5599814 Pyridazinedione compounds useful in treating neurological disorders |
| 02/04/1997 | US5599812 Tricyclic pyrrolopyrazine 5-HT3 -active compounds |
| 02/04/1997 | US5599810 Furo- and thieno[4,3,2-ef][3]benzazepines useful as alpha adrenergic receptor antagonists |
| 02/04/1997 | US5599559 Calcium channel blocking polypeptide from agelenopsis aperta and therapeutic methods employing it |
| 02/04/1997 | US5599388 Acid resistant calcium carbonate composition containing an aluminum salt, uses therefor and processes for its production |
| 02/04/1997 | CA1338894C Aminomethyl-chroman and thiochroman compounds as ó-2-adrenergic antagonists |
| 01/30/1997 | WO1997003473A1 Battery pack housing device and battery pack |
| 01/30/1997 | WO1997003192A2 Chromosome 1 gene and gene products related to alzheimer's disease |
| 01/30/1997 | WO1997003188A2 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 01/30/1997 | WO1997003086A1 Early onset alzheimer's disease gene and gene products |
| 01/30/1997 | WO1997003079A1 Novel quinoxaline- and quinoxalinylalkane-phosphonic acids |
| 01/30/1997 | WO1997003071A1 Heterocyclylcarboxamide derivatives and their use as therapeutic agents |
| 01/30/1997 | WO1997003068A1 A triazolylmethyl-indole ethylamine bisulfate salt |
| 01/30/1997 | WO1997003067A1 Piperazine derivatives as therapeutic agents |
| 01/30/1997 | WO1997003066A1 Substituted benzolactam compounds as substance p antagonists |
| 01/30/1997 | WO1997003065A1 Diphenylmethylene piperidine derivatives |
| 01/30/1997 | WO1997003054A1 BENZO[g]QUINOLINE DERIVATIVES |
| 01/30/1997 | WO1997002828A1 Novel compositions containing phosphoglycero ethers, and use thereof for treating neurodegenerative diseases |
| 01/30/1997 | WO1997002822A1 Drug for ameliorating brain diseases |
| 01/30/1997 | WO1997002817A1 Compounds useful in the treatment of neurofibromatosis |
| 01/30/1997 | WO1997002813A1 Non-allosteric gabaa agonists for treating sleep disorders |
| 01/30/1997 | WO1996035805A3 Tripeptidylpeptidase inhibitors |
| 01/30/1997 | CA2226851A1 Diphenylmethylene piperidine derivatives |
| 01/30/1997 | CA2226658A1 Early onset alzheimer's disease gene and gene products |
| 01/30/1997 | CA2226623A1 Compounds useful in the treatment of neurofibromatosis |
| 01/30/1997 | CA2226340A1 Drug for ameliorating brain diseases |
| 01/30/1997 | CA2226255A1 Chromosome 1 gene and gene products related to alzheimer's disease |
| 01/30/1997 | CA2224718A1 Novel quinoxaline- and quinoxalinylalkane-phosphonic acids |
| 01/30/1997 | CA2224436A1 Benzo [g] quinoline derivatives |
| 01/30/1997 | CA2223472A1 Therapeutic agents |
| 01/29/1997 | EP0755932A1 (Thiophen-2-yl)piperidin or tetrahydropyridin-azabicyclocarboxamides |
| 01/29/1997 | EP0755930A1 Benzoxazepine derivatives, salts thereof, and drugs containing the same |
| 01/29/1997 | EP0755925A1 N,N'-di(aralkyl)-N,N'-di(2-azaaralkyl)alkylene-diamine derivatives and their use in pharmaceutical and cosmetic compositions |
| 01/29/1997 | EP0755682A1 Methods of treatment of motor neuron diseases using members of the BDNF/NT-3/NGF family of molecules |
| 01/29/1997 | EP0755680A2 Use of piperazine compounds as narcotic antagonists |
| 01/29/1997 | EP0755675A1 Dermatological and/or pharmaceutical composition, process of preparation and utilization |
| 01/29/1997 | EP0755454A1 Aav-mediated delivery of dna to cells of the nervous system |
| 01/29/1997 | EP0755404A1 Tachykinin antagonists |
| 01/29/1997 | EP0755398A1 Process for the resolution of etodolac using glucamine derivatives |
| 01/29/1997 | EP0755394A1 A method of inducing cholecystokinin agonist activity using 1,4-benzodiazepine compounds |
| 01/29/1997 | EP0755249A1 Use of maillard reaction inhibitors for the treatment of amyloidosis-based disease |
| 01/29/1997 | EP0652755B1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |
| 01/29/1997 | EP0644772A4 Opioid peptides. |
| 01/29/1997 | EP0635015B1 Acylaminoindole derivatives as 5-ht1 agonists |
| 01/29/1997 | EP0604605A4 Treating disorders by application of insulin-like growth factors and analogs. |
| 01/29/1997 | EP0544748B1 Spiro[cycloalkylbenzene-1,1'-(1',2',3',4'-tetrahydroisoquinolines)] having neuroprotective properties |
| 01/29/1997 | EP0501997B1 N-acyl-substituted azacyclic compounds, processes for their preparation, and their use as pharmaceuticals |
| 01/29/1997 | CN1141630A Substituted pyrazolyl benzenesulfonamides for treating inflammation |
| 01/29/1997 | CN1141625A Vitamin D amine and amine derivatives |
| 01/29/1997 | CN1141297A Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders |
| 01/29/1997 | CA2182226A1 Dermatological or pharmaceutical composition; process for preparing and uses |
| 01/28/1997 | US5597920 Gabaa receptor subtypes and methods for screening drug compounds using imidazoquinoxalines and pyrrolopyrimidines to bind to gabaa receptor subtypes |
| 01/28/1997 | US5597915 Antagonists of cholecystokinin and gastrin receptors |
| 01/28/1997 | US5597842 3-heteroaryl-1-pyrrolidinealkanols and derivatives thereof and their therapeutic utility |
| 01/28/1997 | US5597832 Tetracyclic compounds as dopamine agonists |
| 01/28/1997 | US5597828 Certain 2,4-diamino-5-(2,3-dihalophenyl)-6-substituted pyrimidines which are pharmacologically active CNS compounds |
| 01/28/1997 | US5597827 Treatment of injury of the spinal cord or brain using 4-amino-2-(4-methylpiperazin-1-yl)-5-(2,3,5-trichlorophenyl)pyrimidine |
| 01/28/1997 | US5597826 Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist |
| 01/28/1997 | US5597819 Antiinflammatory agents |
| 01/28/1997 | US5597552 Dentinal desensitizing compositions |
| 01/28/1997 | CA2068232C Pain controlling composition and method of preparation |
| 01/28/1997 | CA2039194C Uses of l-deprenyl and compositions for same |
| 01/27/1997 | CA2182113A1 N,n'-di(aralkyl) n,n'-di(2-azaaralkyl) alkylene diamine derivatives and their use in pharmaceutical and cosmetic compositions |
| 01/27/1997 | CA2181759A1 (thiophen-2-yl)-piperidin or tetrahydropyridin azabicyclocarboxamides |
| 01/23/1997 | WO1997002342A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex |
| 01/23/1997 | WO1997002289A1 Peptide inhibitors of fibronectine |
| 01/23/1997 | WO1997002269A1 Condensed thiazole derivatives, having 5-ht receptor affinity |
| 01/23/1997 | WO1997002259A1 1,6-disubstituted isochromans for treatment of migraine headaches |
| 01/23/1997 | WO1997002254A1 Quinazoline derivatives |
| 01/23/1997 | WO1997002250A1 10-ACYLOXY-10,11-DIHYDRODIBENZ/b,f/AZEPINE-5-CARBOXAMIDES USEFUL FOR TREATING NERVOUS SYSTEM DISORDERS |
| 01/23/1997 | WO1997002248A1 Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use |
| 01/23/1997 | WO1997002049A1 Neuronal progenitor cells and uses thereof |
| 01/23/1997 | WO1997000063A3 Urocortin peptides |
| 01/23/1997 | CA2226417A1 Neuronal progenitor cells and uses thereof |
| 01/23/1997 | CA2225282A1 1,6-disubstituted isochromans for treatment of migraine headaches |
| 01/23/1997 | CA2222725A1 Therapeutic agents |
| 01/22/1997 | EP0754687A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/22/1997 | EP0754455A1 Pharmaceutical compositions based on aminomethylindoles and their therapeutical application as neuroprotectors in parkinson and alzheimer diseases |
| 01/22/1997 | EP0754454A1 Cholinesterase activator |
| 01/22/1997 | EP0754302A1 Methods and apparatus for synthesizing labeled combinatorial chemical libraries |
| 01/22/1997 | EP0754234A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICE rel-II) |
| 01/22/1997 | EP0754189A1 Receptor modulating agents and methods relating thereto |
| 01/22/1997 | EP0754183A1 Novel spiro[indole-pyrrolidine] derivatives as melatoninergic agonists, method for preparing same and use thereof as a drug |
| 01/22/1997 | EP0754060A1 NEW COMBINATION OF A $g(b)-RECEPTOR BLOCKER AND A LOCAL ANAESTHETIC |
| 01/22/1997 | EP0754041A1 Novel substituted tryptamines, phenalkylamines and related compounds |
| 01/22/1997 | EP0754040A1 Rapamycin derivatives |
| 01/22/1997 | EP0754033A1 Heterofunctional, mucoadhesive dosage form |
| 01/22/1997 | EP0698024B1 [1,2,4]TRIAZOLO [4,3-a]QUINOXALINE COMPOUNDS, THEIR PREPARATION AND USE |
| 01/22/1997 | EP0687177B1 Use of lamotrigine for treating aids-related neural disorders |
| 01/22/1997 | EP0644763B1 Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine isethionate for the treatment and prevention of dependence, tolerance and sensitization of drugs |